Logo Image
News
Media
Peer ExchangeCase-Based Psych PerspectivesClinical Case CollectiveClinical Forum InsightsInsightsPeers & PerspectivesPodcastsShortsSlideshowsVideos
Conferences
Conference CoverageConference Listing
Publication
Psychiatric Times
More
Job Board
CME/CE
Partners
Editorial
Resources
Between the LinesExpert PerspectivesClinical ConsultClinical ScalesInteractive ToolsLive EventsPartner PerspectivesQ&AQuizzesSeriesSpecial ReportsSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Publication
  • Job Board
  • CME/CE
  • Partners
  • Editorial
  • Resources
  • Subscribe
  • ADHD
  • Addiction & Substance Use
    • Behavioral Addictions
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Amphetamine Related Disorders
    • Substance Use Disorder
  • Alzheimer Disease & Dementia
  • Anxiety Disorders
    • Panic Disorder
  • Cannabis
  • Case Discussions
  • Comorbidity
  • Consultation-Liaison Psychiatry
    • COVID-19
  • Cultural Psychiatry
  • Drug Watch
  • Eating Disorders
  • Emergency Psychiatry
  • Ethics
  • Forensic Psychiatry
    • Munchausen Syndrome
    • Sexual Offenses
  • Integrative Psychiatry
  • Life Cycle Psychiatry
    • Postpartum Disorders
    • Geriatric Psychiatry
    • Child & Adolescent Psychiatry
  • Mental Health Awareness Month
  • Mood Disorders
    • Treatment-Resistant Depression
    • Major Depressive Disorder
    • Bipolar Disorder
  • Neuromodulation
  • Neuropsychiatry
    • Cognition
    • Dementia
    • Autism
  • Obsessive-Compulsive Disorders
  • PTSD, Trauma & Stress Disorders
    • Disaster Psychiatry
    • Trauma And Violence
    • Traumatic Stress Disorders
  • Personality Disorders
    • Compulsive Personality Disorder
    • Dependent Personality Disorder
    • Dissociative Identity Disorder
    • Histrionic Personality Disorder
    • Schizoid Personality Disorder
    • Antisocial Personality Disorder
    • Borderline Personality
  • Psychedelics & Cannabis
  • Psychiatry & Society
    • Diversity, Equity, Inclusion
    • Climate Change
    • Media & Psychiatry
  • Psychopharmacology
  • Psychosomatics
    • Delirium
    • Metabolic Disorders
    • Somatoform Disorder
  • Psychotherapy
    • Cognitive Behavioral Therapy
  • Schizophrenia/Psychosis
    • Paranoid Schizophrenia
    • Psychotic Affective Disorders
    • Schizoaffective
    • Schizophrenia Psychotic Features
    • Schizotypal Personality Disorder
    • Catatonic Schizophrenia
  • Sleep-Wake Disorders
    • Narcolepsy
    • Nocturnal Paroxysmal Dystonia
    • Sleep Deprivation
    • Sleep Wake Transition
    • Circadian Rhythm Sleep Disorders
  • Special Populations
    • Sports Psychiatry
    • Pervasive Developmental Disorder
    • LGBTQ+
    • Gender Issues
    • Military Mental Health
  • Suicide
  • Tardive Dyskinesia
  • Technology & Psychiatry
    • Digital Therapeutics
    • Artificial Intelligence
Spotlight -
Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|
Major Depressive Disorder
Advertisement

Duncan B. Clark, MD, PhD

Advertisement

Articles by Duncan B. Clark, MD, PhD

Treating Adolescents With Major Depression and an Alcohol Use Disorder

ByJack R. Cornelius, MD, MPH,Oscar G. Bukstein, MD, MPH,Duncan B. Clark, MD, PhD
October 1st 2006

Alcohol is the drug of choice for adolescents, with cigarettes and marijuana being second and third. Contrary to widespread belief, alcohol dependence is most common in 18- to 20-year-olds, with progressively decreasing rates of alcohol dependence in older age groups.

Advertisement

Latest Updated Articles

  • Treating Adolescents With Major Depression and an Alcohol Use Disorder
    Treating Adolescents With Major Depression and an Alcohol Use Disorder

    October 1st 2006



Advertisement
Advertisement

Trending on Psychiatric Times

1

Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us

2

FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms

3

Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement

4

Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD

5

Bringing Wearable Data Into Psychiatric Care: Amae Health Partners With Google Health Enterprise to Improve Outcomes

  • About
  • Advertise
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us